FDA Approves New Drug to Slow Alzheimer's Disease : comparem

The FDA today approved a new therapy for early Alzheimer's disease that appears to modestly slow the progression of the disease that affects more than 6.5 million Americans.

Related Keywords

United States , Americans , Teresa Buracchio , Medicaid Services , Us Medicare Program , Centers For Medicare , Office Of Neuroscience , Drug Evaluation , Novel Alzheimer , Disease Treatment , Traditional Approval , Annual Spending , Its Ancillary Costs , Alzheimers Disease , Lzheimer Disease , Dementia , Us Food And Drug Administration , Nited States Food And Drug Administration , Fda , Cognitive Deficit , Memory Problems , Cognitive Impairment , Cognition , Memory , Medicare , Brain , Amyloid Plaque , Medicaid ,